On 17th June 2022 Ovagen Group Ltd. was selected by the European Commission for €10M in grant and equity funding in what was the most competitive round of European Innovation Council (EIC) Accelerator funding to date, with only 7% of the over 1,000 companies across Europe being funded. This is the second time Ovagen has been successfully awarded funding by the European Commission. This award comprises of €2.5M grant from the EIC and €7.5M in equity supported by the European Investment Bank (EIB). This funding will allow Ovagen provide scientific data to support key attributes of germ free eggs and to accelerate scale up of production and commercialisation.
You can read the full article from Enterprise Ireland by clicking here